Recruiting
Early Phase 1

Pilot Study of the IL-1 Antagonist Anakinra for the Treatment of Endometriosis Related Symptoms

Sponsor:

UCLA

Code:

NCT03991520

Conditions

Endometriosis

Anakinra

Markers of Inflammation

Eligibility Criteria

Sex: Female

Age: 18 - 45

Healthy Volunteers: Not accepted

Interventions

Anakinra 100Mg/0.67Ml Inj Syringe

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information